In the Season 3 premiere of Neurotech Pub, we explore the latest advancements in neurotechnology, focusing on wireless power transfer, implantable devices, and brain-computer interfaces (BCIs). The conversation highlights transformative innovations in treating mental health conditions like major depressive disorder, OCD, and ADHD with less invasive wireless devices, enhancing patient care and acceptance. Personal stories and insights on market expansion and patient-friendly treatments are shared, along with valuable advice for investors on the potential of neurotechnology in improving overall mental health and medical care.
Our guests are:
- Jacob Robinson, PhD, Founder and CEO of Motif Neurotech
- Grayson Zulauf, PhD, CEO of Resonant Link
- Alexander Yeh, PhD, CTO of Neuspera Medical
Show Notes:
00:00 | Welcome to Neurotech Pub
00:46 | Meet the guests
02:43 | Discussing industry competitors
09:55 | Wireless power transfer in medical devices
16:38 | Exploring inductive and magnetoelectric power
27:35 | Ultrasound in real world devices
33:31 | Patient experience and device miniaturization
36:24 | Designing for patient comfort and practicality
38:20 | Innovations in power and data transmission
39:32 | Miniaturization and its impact
41:22 | Battery technology in medical devices
43:19 | Future of implantable batteries
45:10 | Implanted Battery Companies Integer and Resonetics
46:31 | Intermittent stimulation and therapy
49:28 | Power consumption in future implants
59:57 | Data transmission and compression
01:04:56 | Reflections on the journey of medical innovation
01:08:36 | Final thoughts and messages to investors
Want More?
Follow Neurotech Pub on Twitter